EDGAR Filing Documents for 0001104659-21-028270

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001104659-21-028270

Filing Date

2021-02-25

Accepted

2021-02-25 16:31:04

Documents

Period of Report

2021-02-25

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	tm218013d1_6k.htm	6-K	10369
2	EXHIBIT 99.1	tm218013d1_ex99-1.htm	EX-99.1	16954
	Complete submission text file	0001104659-21-028270.txt		28521

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 21680842
SIC: 2834 Pharmaceutical Preparations